Introduction Healthcare databases are useful sources to investigate the epidemiology of chronic obstructive pulmonary disease (COPD), to assess longitudinal outcomes in patients with COPD, and to ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

Chronic obstructive pulmonary disease (COPD) is a prevalent condition affecting approximately 10% of the adult population globally1 and is a leading cause of premature death.2 The disease is ...

The aim of the current study was to assess the validity of the EQ-5D-5L UI and EQ-VAS in a COPD-specific outpatient population by comparing with well-established disease-specific HRQoL questionnaires ...

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...

A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in ...

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic ...

An estimated five percent of the world's population has COPD (chronic obstructive pulmonary disease) and in the U.S., COPD is the third leading cause of death after cancer and heart disease. For Black ...

Patients with COPD experience periods of acute symptom worsening or exacerbations.1 Heart failure (HF) is a common comorbidity in people with COPD, with an estimated global prevalence of HF ...

The 16 emperor penguin colonies in that part of Antarctica represent a third of the global population. The estimated decline compares to an earlier estimate of a 9.5% reduction across Antarctica ...